<DOC>
	<DOCNO>NCT00149994</DOCNO>
	<brief_summary>The purpose study determine whether cyclosporine A ( micro emulsion formulation ) monitor sample take 2 hour oral dose ( C-2h ) show equivalent superior efficacy compare tacrolimus monitor pre-dose blood concentration ( C-0h ) . In addition study ass safety tolerability cyclosporine A regimen base C-2h monitoring comparison standard tacrolimus regimen .</brief_summary>
	<brief_title>Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring de Novo Liver Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Basiliximab</mesh_term>
	<criteria>About undergo primary liver transplant ( include live donor , nonheart beat donor split liver ) . Age 18 75 year . Expected able receive first oral dose CNI within first 24 hour posttransplantation ( Tx ) This multiorgan transplant patient previously transplant organ . Urine production &lt; 200 ml within 12 hour reperfusion graft Severe coexist disease present unstable medical condition present could affect study objective . Other protocoldefined exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Liver transplant , adult , C2 monitoring</keyword>
</DOC>